NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $38.61 0.00 (0.00%) As of 11/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About BioLife Solutions Stock (NASDAQ:BLFS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$38.61▼$38.6150-Day Range$34.92▼$39.2252-Week Range$17.86▼$39.76VolumeN/AAverage Volume1.18 million shsMarket Capitalization$1.89 billionP/E Ratio33.28Dividend YieldN/APrice Target$31.38Consensus RatingHold Company Overview BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business. BioLife has expanded beyond its roots in biopreservation products to offer a broader portfolio for biopharmaceutical and life sciences customers. It serves customers in the United States and internationally, including therapy developers, biopharmaceutical companies and research organizations.AI Generated. May Contain Errors. Read More BioLife Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreBLFS MarketRank™: 1.31991814461 of 5 starsBioLife Solutions scored higher than 26% of companies evaluated by MarketBeat, and ranked 1485th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingBioLife Solutions has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 1 buy rating, 10 hold ratings, and no sell ratings.Downside RiskBioLife Solutions has a consensus price target of $31.38, representing about 18.7% downside from its current price of $38.61.Amount of Analyst CoverageBioLife Solutions has only been the subject of 2 research reports in the past 90 days.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth433.33% Earnings GrowthEarnings for BioLife Solutions are expected to grow by 433.33% in the coming year, from $0.03 to $0.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.70.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.83.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BLFS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment1.13 News SentimentBioLife Solutions has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BioLife Solutions this week, compared to 3 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have not sold or bought any company stock.Percentage Held by Insiders2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLFS Stock News HeadlinesBioLife Solutions (BLFS) Stock Stays Reasonable Despite Its 197% RunNovember 15, 2026 | uk.finance.yahoo.comBioLife Solutions Inc (BLFS) Shares Surge 3.5% -- What GF Score of 67 Tells InvestorsOctober 23, 2026 | gurufocus.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 19 at 1:00 AM | Weiss Ratings (Ad)Can BioLife Solutions (BLFS) Justify Its Price On Future Cash Flow?October 17, 2026 | finance.yahoo.comBioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P 1000October 9, 2026 | marketscreener.comMBioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P Composite 1500October 8, 2026 | marketscreener.comMRepligen Closes BioLife Solutions AcquisitionOctober 6, 2026 | finance.yahoo.comThis long-term winning stock is in a growth market and just hit new 3-year highsSeptember 24, 2026 | msn.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $24.18 at the beginning of the year. Since then, BLFS shares have increased by 59.7% and is now trading at $38.61. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings data on Thursday, August, 6th. The medical equipment provider reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.88. The medical equipment provider earned $28.47 million during the quarter, compared to analyst estimates of $27.80 million. BioLife Solutions had a trailing twelve-month return on equity of 2.70% and a net margin of 53.29%. Who are BioLife Solutions' major shareholders? BioLife Solutions' top institutional investors include Glazer Capital LLC (8.35%), Goldman Sachs Group Inc. (3.72%), State Street Corp (3.38%) and First Trust Capital Management L.P. (2.91%). Insiders that own company stock include Casdin Partners Master Fund, L, Aby J Mathew, Greef Roderick De, Troy Wichterman, Todd Berard, Garrie Richardson, Karen A Foster, Sarah Aebersold, Geraint Phillips, Sean Werner, Joydeep Goswami and Amy Duross. View institutional ownership trends. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include Micron Technology (MU), Alibaba Group (BABA), Block (XYZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Intel (INTC). Company Calendar Last Earnings8/06/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BLFS's financial health is in the Green zone, according to TradeSmith. BLFS has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:BLFS CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees440Year Founded1987Price Target and Rating Average Price Target for BioLife Solutions$31.38 High Price Target$34.00 Low Price Target$31.00 Potential Upside/Downside-18.7%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$1.16 Trailing P/E Ratio33.28 Forward P/E Ratio241.31 P/E GrowthN/ANet Income-$4.59 million Net Margins53.29% Pretax Margin6.28% Return on Equity2.70% Return on Assets2.49% Debt Debt-to-Equity RatioN/A Current Ratio9.69 Quick Ratio7.14 Sales & Book Value Annual Sales$106.69 million Price / Sales17.71 Cash Flow$0.23 per share Price / Cash Flow168.62 Book Value$7.72 per share Price / Book5.00Miscellaneous Outstanding Shares48,923,000Free Float47,847,000Market Cap$1.89 billion OptionableOptionable Beta1.82 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:BLFS) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.